Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc.

NASDAQ:AQST

Overview | Financials
Company Name Aquestive Therapeutics, Inc.
Symbol AQST
Currency USD
Price 4.92
Market Cap 448,014,216
Dividend Yield 0%
52-week-range 1.36 - 6.23
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Daniel Barber
Website https://www.aquestive.com

An error occurred while fetching data.

About Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and

Related Stocks

NexImmune, Inc. logo

NexImmune, Inc.

NEXI

0.32 USD

Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.

ELDN

2.81 USD

Eargo, Inc. logo

Eargo, Inc.

EAR

2.57 USD

Acasti Pharma Inc. logo

Acasti Pharma Inc.

ACST

3.282 USD

Astria Therapeutics, Inc. logo

Astria Therapeutics, Inc.

ATXS

11.76 USD

Zynerba Pharmaceuticals, Inc. logo

Zynerba Pharmaceuticals, Inc.

ZYNE

1.3 USD

Financials

Numbers are in millions USD

Numbers are in millions USD